Breaking News

Ritedose Expands Blow-Fill-Seal Capacity in Columbia, SC

Brings total BFS capacity to more than 2.6 billion units to meet growing demand for ophthalmic and respiratory medications.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The Ritedose Corp., a CDMO specializing in sterile Blow Fill Seal (BFS) production, is significantly expanding its production capabilities to meet demand for ophthalmic and respiratory medications.   The expanded sterile BFS capabilities and new equipment is expected to begin production in August of this year. The addition of another 180-million-unit dose capacity for ophthalmic and respiratory medications aims to meet increasing demand from ophthalmic and respiratory drug developers for high-...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters